ICMH
IBER.WS

Integrity Capital Management (HK)’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Integrity Capital Management (HK)’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-53,425
Closed -$11K – 76
2022
Q1 		$11K Sell
53,425
-24,076
-31% -$7.23K 0.06% 115
2021
Q4 		$42K Buy
+77,501
New +$43.9K 0.13% 136

Other funds holding IBER.WS

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Integrity Capital Management (HK)'s IBER.WS Position: Q2 2022 in Review

Integrity Capital Management (HK) sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q2 2022, closing a stake of 53,425 shares — an estimated $11K sold.

Integrity Capital Management (HK) first reported a position in IBER.WS in Q4 2021 and held it in 2 quarters. The position peaked at $42K in Q4 2021. 36 funds tracked by Wall St. Rank hold IBER.WS as of Q2 2022.

  • Integrity Capital Management (HK) reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
  • Integrity Capital Management (HK) sold 53,425 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q2 2022, an estimated $11K.
  • Integrity Capital Management (HK) first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q4 2021 and held it in 2 quarters.
  • Integrity Capital Management (HK)'s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $42K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q2 2022.

Based on Integrity Capital Management (HK)'s 13F filing for Q2 2022.